Qube Research & Technologies (QRT)
GYRE icon

Qube Research & Technologies (QRT)’s Gyre Therapeutics GYRE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,235
Closed -$109K – 4175
2024
Q1 		$109K Sell
6,235
-510
-8% -$9.19K ﹤0.01% 3269
2023
Q4 		$173K Buy
6,745
+6,744
+674,400% +$95.7K ﹤0.01% 2860
2023
Q3 		$11 Buy
+1
New +$7 ﹤0.01% 3917

Other funds holding GYRE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GYRE Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Gyre Therapeutics (GYRE) in Q2 2024, closing a stake of 6,235 shares — an estimated $109K sold.

Qube Research & Technologies (QRT) first reported a position in GYRE in Q3 2023 and held it in 3 quarters. The position peaked at $173K in Q4 2023. 30 funds tracked by Wall St. Rank hold GYRE as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Gyre Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6,235 Gyre Therapeutics shares in Q2 2024, an estimated $109K.
  • Qube Research & Technologies (QRT) first reported a position in Gyre Therapeutics in Q3 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Gyre Therapeutics position peaked at $173K in Q4 2023.
  • 30 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.